Improved survival of patients with rectal cancer since 1980: A population-based study

European Journal of Cancer

Volumn 39, Issue 14, 2003, Pages 2073-2079

  Martijn, H ^a   Voogd, A C ^b,c   Van De Poll Franse, L V ^b   Van Driel, O J Repelaer ^d   Rutten, H J T ^a   Coebergh, J W W ^b,e  

^a CATHARINA HOSPITAL   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MÁXIMA MEDICAL CENTER   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Patterns of care; Rectal neoplasms; Survival; Trend

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROGNOSIS; RECTUM CARCINOMA; STATISTICAL SIGNIFICANCE; ADOLESCENT; CHILD; HEALTH SURVEY; INFANT; MIDDLE AGED; MORTALITY; NETHERLANDS; NEWBORN; PRESCHOOL CHILD; RECTUM TUMOR; REGISTER; RISK FACTOR; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NETHERLANDS; POPULATION SURVEILLANCE; PROGNOSIS; RECTAL NEOPLASMS; REGISTRIES; RISK FACTORS; SURVIVAL RATE;

EID: 0142121405     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00493-3     Document Type: Article

References (34)

1. De Neve W., Martijn H., Lybeert M.M., Crommelin M., Goor C., Ribot J.G. Incompletely resected rectum, recto-sigmoid, or sigmoid carcinoma. results of postoperative radiotherapy and prognostic factors Int. J. Radiat. Oncol. Biol. Phys. 21:1991;1297-1302.
2. Lybeert M.L.M., Martijn H., de Neve W., Crommelin M.A., Ribot J.G. Radiotherapy for locoregional relapses of rectal carcinoma after initial radical surgery. definite but limited influence on relapse-free survival and survival Int. J. Radiat. Oncol. Biol. Phys. 24:1992;241-246.
3. Martijn H., de Neve W., Lybeert M.L.M., Crommelin M.A., Ribot J.G. Adjuvant postoperative radiotherapy for adenocarcinoma of the rectum and rectosigmoid. Am. J. Clin. Oncol. 18:1995;277-281.
4. Mollen R.M.H.G., Damhuis R.A.M., Coebergh J.W.W. Local recurrence and survival in patients with rectal cancer, diagnosed 1981-86. a community hospital-based study in the south-east Netherlands Eur. J. Surg. Oncol. 23:1997;20-23.
5. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer. 66:1990;49-55.
6. Påhlman L., Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann. Surg. 21:1990;187-195.
7. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Br. J. Surg. 80:1993;1333-1336.
8. Heald R.J., Ryall R.D.H. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. i:1986;1479-1482.
9. MacFarlane J.K., Ryall R.D.H., Heald R.J. Mesorectal excision for rectal cancer. Lancet. 341:1993;457-460.
10. Mannaerts G.H.H., Martijn H., Crommelin M.A.et al. Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 45:1999;297-307.
11. Coebergh J.W.W., Masseling E., van der Heijden L.H., Razenberg P.P.A. Netherlands: Eindhoven. Parkin D.M., Whelan Sh., Ferlay J., Raymond L., Young J. Cancer Incidence in 5 Continents, vol VII. IARC Scientific Publications, No. 143. 1997;586-589 IARC, Lyon.
12. Hermanek P., Sobin L.H.et al. UICC TNM Classification of Malignant Tumours. 1987;Springer-Verlag, Berlin. 47-49.
13. Kapiteijn E., Marijnen C., Nagtegaal I.D.et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 345:2001;638-646.
14. Voutilainen E.T., Dickman P.W., Hakulinen T. SURV2: Relative Survival Analysis Program, ed. 2.02, 3.0. 2001;Karolinska Institute, Helsinki.
15. Ederer F., Axtell L.M., Cutler S.J. The relative survival rate. a statistical methodology Natl. Cancer Inst. Monogr. 6:1961;101-121.
16. Hakulinen T., Tenkanen L. Regression analysis of relative survival rates. Appl. Stat. 36:1987;309-317.
17. Cox D.R. Regression models and life tables [with discussion]. J. Royal Stat. Soc. Ser. B. 34:1972;187-220.
18. Finn-Faivre C., Maurel J., Benhamiche A.M.et al. Evidence of improving survival of patients with rectal cancer in France. a population-based study Gut. 44:1999;377-381.
19. Marijnen C.A.M., Nagtegaal I.D., Klein Kranenbarg E.et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J. Clin. Oncol. 19:2001;1976-1984.
20. Faivre-Finn C., Benhamiche A.M., Maingon P., Janoray P., Faivre J. Changes in the practice of adjuvant radiotherapy in resectable rectal cancer within a French well-defined population. Radiother. Oncol. 57:2000;137-142.
21. Gatta G., Faivre J., Capocaccia R., Ponz de Leon M. Survival of colorectal cancer patients in Europe during the period 1978-1989. EUROCARE Working Group. Eur. J. Cancer. 34:1998;2176-2183.
22. Dahlberg M., Påhlman L., Bergstrom R., Glimelius B. Improved survival in patients with rectal cancer. a population-based register study Br. J. Surg. 85:1998;515-520.
23. McArdle C.S., Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. Br. Med. J. 302:1991;1501-1505.
24. Hermanek P., Wiebelt H., Staimmer D., Riedl S. Prognostic factors of rectum carcinoma- experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori. 81:1995;60-64.
25. Harmon J.W., Tang D.G., Gordon T.A.et al. Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann. Surg. 230:1999;404-411.
26. Blomqvist P., Ekbom A., Nyrén O., Krusemo B.U., Bergström R., Adami H.O. Survival after rectal cancer. differences between hospital catchment areas. A nationwide study in Sweden Gut. 45:1999;39-44.
27. Lehander Martling A., Holm T., Rutqvist L.E., Moran B.J., Heald R.J., Cedermark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. The Stockholm Colorectal Cancer Study Group and the Basingstoke Bowel Cancer Research Project. Lancet. 356:2000;93-96.
28. Improved survival with preoperative radiotherapy in resectable rectal cancer. N. Engl. J. Med. 336:1997;980-987.
29. Kapiteijn E., Putter H., van de Velde C.J.H. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br. J. Surg. 89:2002;1142-1149.
30. Wibe A., Møller B., Norstein J.et al. A National Strategic Change in Treatment Policy for Rectal Cancer- Implementation of Total Mesorectal Excision as Routine Treatment in Norway. A National Audit. Dis. Colon Rectum. 45:2002;857-866.
31. Cammà C., Giunta M., Fiorica F., Pagliora L., Craxì A., Cottone M. Preoperative radiotherapy for resectable rectal cancer. A meta-analysis. JAMA. 284:2000;1008-1015.
32. Adjuvant radiotherapy for rectal cancer. a systematic overview of 8507 patients from 22 randomised trials Lancet. 385:2001;1291-1304.
33. Glimelius B., Isacsson U., Jung B., Påhlman L. Radiotherapy in addition to radical surgery in rectal cancer. evidence for a dose-response effect favoring preoperative treatment Int. J. Radiat. Oncol. Biol. Phys. 37:1997;281-287.
34. De Marco M.F., Janssen-Heijnen M.L.G., van der Heijden L.H., Coebergh J.W.W. Comorbidity and colorectal cancer according to subsite and stage. a population-based study Eur. J. Cancer. 36:2000;95-99.